Analysis of predictive and prognostic factors in 290 patients treated with oncolytic adenoviruses

Documenti analoghi

• Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy
  di: Taipale, Kristian, et al.
  Pubblicazione: (2016)
• Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy
  di: Hemminki, Otto, et al.
  Pubblicazione: (2018)
• Case–Control Estimation of the Impact of Oncolytic Adenovirus on the Survival of Patients With Refractory Solid Tumors
  di: Kanerva, Anna, et al.
  Pubblicazione: (2015)
• Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
  di: Liikanen, Ilkka, et al.
  Pubblicazione: (2015)
• T-cell Subsets in Peripheral Blood and Tumors of Patients Treated With Oncolytic Adenoviruses
  di: Kristian, Taipale, et al.
  Pubblicazione: (2015)